Colonised participants | Non-colonised participants | p Value | |
N | 11 | 122 | |
Spring | |||
Number of COPD exacerbations | 1 (1) | 0.5 (2) | p>0.05 |
% with pneumonia | 0% | 9% | |
Incidents of antibiotic use | 0 (1) | 1 (3) | |
Incidents of steroid use | 1 (1) | 1 (2) | |
Summer | |||
Number of COPD exacerbations | 0 (1) | 1 (2) | p>0.05 |
% with pneumonia | 0% | 3% | |
Incidents of antibiotic use | 0 (2) | 1 (2) | |
Incidents of steroid use | 1 (1) | 1 (2) | |
Autumn | |||
Number of COPD exacerbations | 1 (2) | 1 (3) | p>0.05 |
% with pneumonia | 0% | 2% | |
Incidents of antibiotic use | 2 (2) | 2 (2) | |
Incidents of steroid use | 1 (1) | 1 (2) | |
Winter | |||
Number of COPD exacerbations | 0 (1) | 1 (2) | 0.06 |
% with pneumonia | 0% | 2% | p>0.05 |
Incidents of antibiotic use | 0 (0.5) | 1 (2) | *0.01 |
Incidents of steroid use | 0 (0) | 1 (2) | *0.01 |
Data presented as median (IQR) or % unless otherwise specified.
*significance at p=0.01 level.